The FY14 Defense Appropriations Act provides $20 million (M) to the Department of Defense Gulf War Illness Research Program (GWIRP) to support innovative, high-impact research to improve the health and lives of veterans who have Gulf War Illness (GWI). This pre-announcement will allow investigators time to plan and develop applications. FY14 GWIRP Program Announcements and General Application Instructions for the following award mechanisms are anticipated to be posted on Grants.gov in early September 2014. Pre-application and application deadlines will be available when the Program Announcements are released.
Program to be announced: Innovative Treatment Evaluation Award 2
- PI can be an independent investigator at any academic level. Collaboration with industry and/or academic partners is encouraged.
- Supports small-scale, early clinical trial evaluations of innovative treatments not previously studied in GWI. Pilot Phase 0, I, and I/II clinical trials are allowed. Provides opportunity to obtain proof of principle data to support future clinical trials. Preliminary data are not required, and if provided, do not necessarily have to come from the GWI research field. Studies with clear potential to move forward to Phase II/III clinical trials are encouraged. Collaboration with industry and/or academic partners is encouraged.
- Maximum funding of $450,000 for direct costs. Period of performance not to exceed 3 years. Indirect costs may be proposed in accordance with the institution’s rate agreement.
CDMRP web site: http://cdmrp.army.mil/funding/default.shtml
Filed Under: Funding Opportunities